Where did you read that we needed 3000 patients for a B-ABSSSI phase 3 trial? Did I miss that somewhere? Or was that figured based off the dollar amount?
My understanding a couple years ago was that we expected two arms (adult/children maybe?) ~700 patients (x2 perhaps?). This is the first I heard of such a large number.
Go IPIX!
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.